Skip to main content
Gemina Laboratories Ltd. logo

Gemina Laboratories Ltd. — Investor Relations & Filings

Ticker · GLAB LEI · 9845006E1B1D0E9T0F50 CSE Manufacturing
Filings indexed 108 across all filing types
Latest filing 2023-06-01 Regulatory Filings
Country CA Canada
Listing CSE GLAB

About Gemina Laboratories Ltd.

https://www.geminalabs.com/

Gemina Laboratories Ltd. is a biotechnology company specializing in the research, development, and commercialization of in-vitro diagnostics (IVD) and biosensing technologies. The company designs, builds, and sells Point-of-Care (PoC) diagnostics products, with a primary focus on applications for respiratory diseases. Gemina Labs utilizes a proprietary, patented surface binding chemistry platform, described as transformative, which underpins its next-generation biosensing solutions. This breakthrough chemistry is intended to fundamentally advance the rapid IVD sector. The company also operates within the broader human wellness monitoring market.

Recent filings

Filing Released Lang Actions
Audited annual financial statements – English.pdf
Regulatory Filings
2023-06-01 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2023-06-01 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2023-06-01 English
Material change report - English.pdf
Regulatory Filings
2023-04-05 English
Report of exempt distribution excluding schedule 1 of Form 5.PDF
Regulatory Filings
2023-04-04 English
Material change report - English.PDF
Regulatory Filings
2023-02-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.